Tikvah Therapeutics Licenses Academia Sinica Patent Estate Related to the Diagnosis, Method of Use, and Treatment of Neurodegenerative Diseases Including Spinal Muscular Atrophy
July 24, 2007 08:00 ET
|
Tikvah Therapeutics, Inc.
ATLANTA, July 24, 2007 (PRIME NEWSWIRE) -- Tikvah Therapeutics, Inc. (Tikvah) and Academia Sinica of Taipei, Taiwan announced today that Tikvah has entered into an exclusive licensing agreement for a...
Tikvah Therapeutics Enters an Exclusive Licensing Agreement With Apkarian Technologies Related to Agents for Treatment of Pain and Pain-Related Indications
July 16, 2007 13:09 ET
|
Tikvah Therapeutics, Inc.
ATLANTA, July 16, 2007 (PRIME NEWSWIRE) -- Tikvah Therapeutics, Inc. (Tikvah) and Chicago-based Apkarian Technologies, LLC (Apkarian) announced today that Tikvah has entered into an exclusive...
Tikvah Therapeutics Raises $10 Million Gross Proceeds in Private Financing
July 12, 2007 08:00 ET
|
Tikvah Therapeutics, Inc.
ATLANTA, July 12, 2007 (PRIME NEWSWIRE) -- Tikvah Therapeutics, Inc., a biopharmaceutical company that focuses on novel therapeutic treatments for diseases of the central nervous system, including...